Cerner Health Conference

Researchers at Stanford University have demonstrated for the first time the use of a dual optical and positron emission tomography (PET)/computed tomography (CT) activity-based probe to detect atherosclerotic plaques. The study is published in the October issue of The Journal of Nuclear Medicine.

November 1, 2016 — Two new studies have documented the value of the BioZorb marker in improving the treatment of women who have breast cancer.

The first study, a peer-reviewed article appearing in the World Journal of Surgery, outlines how the three-dimensional, bioabsorbable marker provides more accurate targeting of the cancer tumor bed for radiation treatment when implanted during surgery.

Specifically training oncologists and their patients to have high-quality discussions improves communication, but troubling gaps still exist between the two groups, according to a new study in JAMA Oncology.

Konica Minolta announced it will be introducing a series of new ultrasound accessories and technologies at the 2016 annual meeting of the Radiological Society of North America, Nov. 27-Dec. 2 in Chicago.

For a long time, the ongoing joke on the floor of the McCormick Place after Thanksgiving was that RSNA stood for Real Systems Not Available. And, like all humor that lasts, there is truth to it. But that truth is changing. 

Using magnetic resonance imaging (MRI), researchers at Washington University School of Medicine in St. Louis have identified areas in the brains of children with Tourette's syndrome that appear markedly different from the same areas in the brains of children who don't have the neuropsychiatric disorder.

mammography

Mammography has been the gold standard for breast cancer screening ever since it was proven to reduce mortality in clinical trials in the 1960s. A 2015 report from the U.S. Department of Health and Human Services (HHS) revealed, however, that only 66.8 percent of women age 40 and over — the demographic traditionally targeted for screening — had received a mammogram in the previous two years.1 Understanding of fibroglandular breast density and its impact on cancer detection, as well as new screening guidelines that challenge conventional wisdom, are among the factors impacting compliance rates, and they suggest that screening has evolved beyond the one-size-fits-all approach of using mammography alone.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now